SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-115829
Filing Date
2023-11-08
Accepted
2023-11-08 17:28:04
Documents
5
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2330243-1_def14a.htm DEF 14A 495004
2 GRAPHIC bc_paidvstsr-4c.jpg GRAPHIC 50982
3 GRAPHIC bc_paidvsnetloss-4c.jpg GRAPHIC 46748
4 GRAPHIC px_23brainpxy01pg01-bw.jpg GRAPHIC 230418
5 GRAPHIC px_23brainpxy01pg02-4c.jpg GRAPHIC 177100
  Complete submission text file 0001104659-23-115829.txt   1126541
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36641 | Film No.: 231389360
SIC: 2836 Biological Products, (No Diagnostic Substances)